Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lonsurf (trifluridine and tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer

Drug (Brand / Generic)

Lonsurf (trifluridine and tipiracil)

Company / Licensee

Taiho Oncology

Therapy Class

Metabolic / thymidine phosphorylase inhibitor

Current Indication

Metastatic colorectal cancer (mCRC)

Market Sector

Oncology

Development Status

Approved in the US and Japan
Expand

Go Top